CAMBRIDGE, Mass.--(BUSINESS WIRE)--June 7, 2006--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY - News), a leading RNAi therapeutics company, today announced that management will present a company overview at the Fifth Annual Needham & Company, LLC Biotechnology and Medical Technology Conference on Wednesday, June 14, 2006 at 4:00 p.m. ET at the Palace Hotel in New York.
